| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 541983 | Innovative Ideal Innovative Ideals and Services India Ltd | 26-May-2026 | Innovative Ideals And Services (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the half year and financial year ended on March 31 2026 |
| 542013 | Dolfin Rubbers Dolfin Rubbers Ltd | 26-May-2026 | Audited Results Dolfin Rubbers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve This is to inform you that Pursuant to the provision of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 26th May, 2026 to transact the following business: 1. Consider and approve the audited Financial Results of the Company for the fourth quarter and financial year ended 31st March, 2026. 2. To consider any other matter with the permission of the Chairperson. Further, notice is hereby given that, as per Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the company has already intimated to Exchange on 26th March, 2026 that the 'Trading Window' for dealing in the Equity Shares of the Company will remain close for all Promoters and Designated Persons from 01st April, 2026 till the end of 48 hours after declaration of the Financial Results by the Company for the financial year ended 31st March, 2026 |
| 542376 | SPA CAPT SER SPA Capital Services Ltd | 26-May-2026 | SPA Capital Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Audited Financial Results for the fourth quarter and year ended 31st March 2026. |
| 506162 | Terraform Magnum Terraform Magnum Ltd | 26-May-2026 | Terraform Magnum Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve To consider approve and take on record the Audited Financial Statements (Standalone) for the quarter and the financial year ended March 31 2026 and the Audited Financial Results (Standalone) for the quarter and the financial year ended March 31 2026 along with the Audit Reports of the Statutory Auditors. To consider any other business item with the permission of the Chair. |
| 506285 | Bayer Crop Sci. Bayer CropScience Ltd | 26-May-2026 | Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended on March 31 2026 and to consider the recommendation of Final Dividend for the Financial Year 2025-26 if any. |
| 506414 | Fermenta Biotec. Fermenta Biotech Ltd | 26-May-2026 | Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31 2026 and consideration of final equity dividend if any. |
| 506642 | Sadhana Nitro Sadhana Nitro Chem Ltd | 26-May-2026 | Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve inter alia: 1. To consider the Audited Standalone and Consolidated Financial Results and Statements for the quarter and Financial year ended March 31 2026. 2. To Consider the recommendation of Dividend for the financial year 2025-26. 3. Any other business that may arise out of the discussion during the meeting |
| 506687 | Transpek Inds. Transpek Industry Ltd | 26-May-2026 | Transpek Industry Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve the Audited Financial Results of the Company for the 31st March, 2026 and to consider recommendations of Dividend, if any, for the financial year 2025-26. |
| 506820 | Astrazeneca Phar Astrazeneca Pharma India Ltd | 26-May-2026 | Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve 1. The audited financial results of the Company for the quarter and year ended March 31 2026. 2. To recommend Dividend if any on the equity shares of the Company for the financial year 2025-26. We also inform you that the Trading Window remains closed for all Designated Persons from March 16 2026 to May 28 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015. |
| 506919 | Makers Labs. Makers Laboratories Ltd | 26-May-2026 | Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Standalone and Consolidated Audited Financial Results for 4th quarter and financial year ended 31st March 2026 |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
